177 related articles for article (PubMed ID: 35637242)
1. Structure of the glucosyltransferase domain of TcdA in complex with RhoA provides insights into substrate recognition.
Chen B; Liu Z; Perry K; Jin R
Sci Rep; 2022 May; 12(1):9028. PubMed ID: 35637242
[TBL] [Abstract][Full Text] [Related]
2. Structural determinants of Clostridium difficile toxin A glucosyltransferase activity.
Pruitt RN; Chumbler NM; Rutherford SA; Farrow MA; Friedman DB; Spiller B; Lacy DB
J Biol Chem; 2012 Mar; 287(11):8013-20. PubMed ID: 22267739
[TBL] [Abstract][Full Text] [Related]
3. Development of a non-radiolabeled glucosyltransferase activity assay for C. difficile toxin A and B using ultra performance liquid chromatography.
Loughney JW; Lancaster C; Price CE; Hoang VM; Ha S; Rustandi RR
J Chromatogr A; 2017 May; 1498():169-175. PubMed ID: 28238427
[TBL] [Abstract][Full Text] [Related]
4. Substrate specificity of clostridial glucosylating toxins and their function on colonocytes analyzed by proteomics techniques.
Zeiser J; Gerhard R; Just I; Pich A
J Proteome Res; 2013 Apr; 12(4):1604-18. PubMed ID: 23387933
[TBL] [Abstract][Full Text] [Related]
5. TcdB of
Stieglitz F; Gerhard R; Hönig R; Giehl K; Pich A
Int J Mol Sci; 2022 Apr; 23(8):. PubMed ID: 35457076
[TBL] [Abstract][Full Text] [Related]
6. Toward a structural understanding of Clostridium difficile toxins A and B.
Pruitt RN; Lacy DB
Front Cell Infect Microbiol; 2012; 2():28. PubMed ID: 22919620
[TBL] [Abstract][Full Text] [Related]
7. Use of a neutralizing antibody helps identify structural features critical for binding of
Kroh HK; Chandrasekaran R; Rosenthal K; Woods R; Jin X; Ohi MD; Nyborg AC; Rainey GJ; Warrener P; Spiller BW; Lacy DB
J Biol Chem; 2017 Sep; 292(35):14401-14412. PubMed ID: 28705932
[No Abstract] [Full Text] [Related]
8. High temporal resolution of glucosyltransferase dependent and independent effects of Clostridium difficile toxins across multiple cell types.
D'Auria KM; Bloom MJ; Reyes Y; Gray MC; van Opstal EJ; Papin JA; Hewlett EL
BMC Microbiol; 2015 Feb; 15(1):7. PubMed ID: 25648517
[TBL] [Abstract][Full Text] [Related]
9. Autoproteolytic cleavage mediates cytotoxicity of Clostridium difficile toxin A.
Kreimeyer I; Euler F; Marckscheffel A; Tatge H; Pich A; Olling A; Schwarz J; Just I; Gerhard R
Naunyn Schmiedebergs Arch Pharmacol; 2011 Mar; 383(3):253-62. PubMed ID: 21046073
[TBL] [Abstract][Full Text] [Related]
10. Haemorrhagic toxin and lethal toxin from Clostridium sordellii strain vpi9048: molecular characterization and comparative analysis of substrate specificity of the large clostridial glucosylating toxins.
Genth H; Pauillac S; Schelle I; Bouvet P; Bouchier C; Varela-Chavez C; Just I; Popoff MR
Cell Microbiol; 2014 Nov; 16(11):1706-21. PubMed ID: 24905543
[TBL] [Abstract][Full Text] [Related]
11. Human α-Defensin-6 Neutralizes
Barthold L; Heber S; Schmidt CQ; Gradl M; Weidinger G; Barth H; Fischer S
Int J Mol Sci; 2022 Apr; 23(9):. PubMed ID: 35562899
[TBL] [Abstract][Full Text] [Related]
12.
Schweitzer T; Genth H; Pich A
Int J Mol Sci; 2022 Sep; 23(17):. PubMed ID: 36077344
[No Abstract] [Full Text] [Related]
13. Cytotoxicity of Clostridium difficile toxin B does not require cysteine protease-mediated autocleavage and release of the glucosyltransferase domain into the host cell cytosol.
Li S; Shi L; Yang Z; Feng H
Pathog Dis; 2013 Feb; 67(1):11-8. PubMed ID: 23620115
[TBL] [Abstract][Full Text] [Related]
14. Neutralizing epitopes on
Chen B; Perry K; Jin R
Front Immunol; 2022; 13():978858. PubMed ID: 36466927
[TBL] [Abstract][Full Text] [Related]
15. Difference in F-actin depolymerization induced by toxin B from the Clostridium difficile strain VPI 10463 and toxin B from the variant Clostridium difficile serotype F strain 1470.
May M; Wang T; Müller M; Genth H
Toxins (Basel); 2013 Jan; 5(1):106-19. PubMed ID: 23344455
[TBL] [Abstract][Full Text] [Related]
16. Human peptide α-defensin-1 interferes with Clostridioides difficile toxins TcdA, TcdB, and CDT.
Fischer S; Ückert AK; Landenberger M; Papatheodorou P; Hoffmann-Richter C; Mittler AK; Ziener U; Hägele M; Schwan C; Müller M; Kleger A; Benz R; Popoff MR; Aktories K; Barth H
FASEB J; 2020 May; 34(5):6244-6261. PubMed ID: 32190927
[TBL] [Abstract][Full Text] [Related]
17. A neutralizing antibody that blocks delivery of the enzymatic cargo of
Kroh HK; Chandrasekaran R; Zhang Z; Rosenthal K; Woods R; Jin X; Nyborg AC; Rainey GJ; Warrener P; Melnyk RA; Spiller BW; Lacy DB
J Biol Chem; 2018 Jan; 293(3):941-952. PubMed ID: 29180448
[No Abstract] [Full Text] [Related]
18. Low Density Lipoprotein Receptor-Related Protein-1 (LRP1) Is Involved in the Uptake of
Schöttelndreier D; Langejürgen A; Lindner R; Genth H
Front Cell Infect Microbiol; 2020; 10():565465. PubMed ID: 33194803
[TBL] [Abstract][Full Text] [Related]
19. Human intestinal enteroids as a model of
Engevik MA; Danhof HA; Chang-Graham AL; Spinler JK; Engevik KA; Herrmann B; Endres BT; Garey KW; Hyser JM; Britton RA; Versalovic J
Am J Physiol Gastrointest Liver Physiol; 2020 May; 318(5):G870-G888. PubMed ID: 32223302
[No Abstract] [Full Text] [Related]
20. Isofagomine Inhibits Multiple TcdB Variants and Protects Mice from
Paparella AS; Brew I; Hong HA; Ferriera W; Cutting S; Lamiable-Oulaidi F; Popadynec M; Tyler PC; Schramm VL
ACS Infect Dis; 2024 Mar; 10(3):928-937. PubMed ID: 38334357
[No Abstract] [Full Text] [Related]
[Next] [New Search]
